Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Ignasi Clotet S L U has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This case is assigned to 1 distinct examiner and 1 distinct art unit. The company's current patent activity is highly specialized, focusing on a single active matter.
ROSENTHAL, ANDREW S is the busiest examiner for the company, currently managing the 1 pending office action. Since there is only 1 distinct examiner involved, this person is the sole reviewer for the company's current pending portfolio. This allows for a direct and consistent prosecution experience for the 1 pending office action.
The 1 distinct art unit indicates that the company's innovation is classified within a specific technical group in Biotechnology & Pharmaceuticals. With 1 pending office action, the company's immediate prosecution needs are minimal. This profile shows a very targeted and efficient approach to intellectual property management under the 1 distinct examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSENTHAL, ANDREW S | 1 | 51.8% | +38.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689575 | CHEMICAL COMPOSITION, METHOD FOR MANUFACTURING HYPOCHLOROUS ACID FOR OBTAINING SAID CHEMICAL COMPOSITION AND INSTALLATION TO PERFORM SAID METHOD | ROSENTHAL, ANDREW S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689575 | CHEMICAL COMPOSITION, METHOD FOR MANUFACTURING HYPOCHLOROUS ACID FOR OBTAINING SAID CHEMICAL COMPOSITION AND INSTALLATION TO PERFORM SAID METHOD | ROSENTHAL, ANDREW S | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18689575 | CHEMICAL COMPOSITION, METHOD FOR MANUFACTURING HYPOCHLOROUS ACID FOR OBTAINING SAID CHEMICAL COMPOSITION AND INSTALLATION TO PERFORM SAID METHOD | ROSENTHAL, ANDREW S | 1613 | §103§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial